RARRES2 and metabolic dysfunction-associated steatotic liver disease: Epidemiological studies reported that serum chemerin levels were generally higher in NAFLD or SS patients relative to controls, but there was no evident difference in circulating chemerin levels between NASH and healthy controls, and between NASH and SS patients (53).